Search Protocols under revision. Back New search Go to resultsDiseaseMain groupCross-Sectional, Transplantation, Cellular TherapySolid TumorsProtocol groupGastroenterologic OncologyGynecological OncologyThoracic TumorsTumor, regardless of entityVisceral SurgeryDiseaseBreast CancerGastric CancerLung Carcinoma, Non-Small CellLung Carcinoma, Small CellOvarian TumorPeritoneal Carcinomatosis, SecondaryTumor, Various OrgansSubgroupEpCAM positiveICD10C16.-C16.0C34.-C50.-C56C78.6MeSHBreast NeoplasmsCarcinoma, Ovarian EpithelialOvarian NeoplasmsPeritoneal NeoplasmsSmall Cell Lung CarcinomaStomach NeoplasmsSequenceAntineoplastic therapySubstanceCatumaxomabCisplatinNaCl 0.9%SubstanceCatumaxomabCisplatinNaCl 0.9%SubstanceCatumaxomabCisplatinNaCl 0.9%SubstanceCatumaxomabCisplatinNaCl 0.9%No. Substances12 RadiotherapySupportive therapySubstanceGranisetronNaCl 0.9%ParacetamolSubstanceGranisetronNaCl 0.9%ParacetamolSubstanceGranisetronNaCl 0.9%ParacetamolSubstanceGranisetronNaCl 0.9%ParacetamolNo. Substances3Protocol classificationTherapy classificationalternativeIntensityStandard doseTherapy indicationseveral possibleTherapy phaseTherapy intentionpalliativeRisksAnemia Hb below 8g/dlCardiotoxicityDiarrheaEmetogenicityEmetogenicity (MASCC/ESMO)Increase AminotransferasesLymphopeniaPyrexia only studiesPublicationAuthorHeiss MMMaisch BDiseaseMaligner Perikarderguss, hämodynamisch relevantPeritonealkarzinose, sekundär, EpCAM positivOriginCologne-Merheim Medical Center, University of Witten-Herdecke, Cologne, GermanyDepartment of Internal Medicine-Cardiology, Philipps University, Marburg, GermanyProtocols in Revision 2 protocols foundCatumaxomab (10/20/50/150), Peritoneal Carcinomatosis, Secondary (PID3037 V1.0)Cisplatin 30, Tumor, Various Organs (PID2371 V1.0)
